BioSpace News Archive

Atlantic Therapeutics, a global medical device manufacturer, today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive, clinically proven and wearable device for the treatment of stress urinary incontinence (SUI) in adult females.

REDWOOD CITY, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that its fourth quarter and full year 2019 financial results will be released after market close on Thursday, February 27, 2020.

Feb. 6, 2020 15:00 UTC Former U.S. FDA Reviewer for Endovascular Devices Joins Global CRO NEW YORK--( BUSINESS WIRE )-- Syntactx, a global, full-service clinical research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the company as Vice President, Regulatory Strategy. In this newly established role, Dorothy oversees the development and execution of regulatory plans designed to

270Surgical Ltd. (the “Company”) announced today that an abstract featuring new data for its SurroundScope System was selected for a podium presentation at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, which is taking place from April 1st – 4th at the Huntington Convention Center in Cleveland, OH.

The American College of Prosthodontists invite dental professionals to Chicago, Feb. 18-19 [06-February-2020] CHICAGO , Feb. 6, 2020 /PRNewswire/ -- The American College of Prosthodontists (ACP) is pleased to announce the 2020 Digital Dentistry Symposium is returning to Chicago , Feb 18-19 . This year will provide attendees ‘Solutions & Strategies for Success’

Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions

macro-eyes will bring AI to where it will do the greatest good

Media are invited to send cameras to shoot b-roll of the repatriation facilities set up for Canadians returning from Wuhan, China, due to the novel coronavirus.

Awaiting completion of FINRA approval process Dividends remain the same Shareholders to receive 2 to 5 stock dividend of Generex Biotechnology shares plus an additional 2 to 5 stock dividend of NuGenerex Immuno-Oncology shares

Minimum wage increased from $12.50 to $13.50 to continue to lead industry in Charlotte region